本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

46.04
-0.0400-0.09%
盘后46.040.00000.00%16:52 EDT
成交量:67.94万
成交额:3,142.59万
市值:35.13亿
市盈率:61.39
高:47.17
开:46.36
低:45.71
收:46.08
52周最高:49.12
52周最低:18.26
股本:7,629.42万
流通股本:3,524.44万
量比:0.95
换手率:1.93%
股息:- -
股息率:- -
每股收益(TTM):0.7500
每股收益(LYR):0.7500
净资产收益率:11.73%
总资产收益率:7.18%
市净率:6.19
市盈率(LYR):61.39

数据加载中...

2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/24

重要事件披露

Form 8-K - Current report
2026/01/14

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities